Larimar Therapeutics (NASDAQ:LRMR) Director Frank Thomas Acquires 8,000 Shares of Stock
One daysingle sourceOne outlet reported this, once - no second voice in this corpus.
All 1 reports on Fri, 13 November 2026
What it is about
Frank ThomasNasdaqSecurities Exchange CommissionDimensional Fund AdvisorsCapital ManagementRenaissance TechnologiesLarimar Therapeutics Company ProfileBala Cynwyd, Pennsylvania, United StatesPennsylvania, United StatesBlackrock, Pennsylvania, United States
Who published it, and when
How it spread - 1 original report
Fri, 13 November 2026
1 report- dailypolitical.com01:30first to report
Larimar Therapeutics, Inc. (NASDAQ:LRMR – Get Free Report) Director Frank Thomas purchased 8,000 shares of the company’s stock in a transaction that occurred on Wednesday, November 11th. The shares were acquired at an average price of $2.73 per share, for a total transaction of $21,840.00. Following the completion of the acquisition, the director directly owned […]